Despite major shifts in policies for prevention of mother-to-child HIV transmission (PMTCT) there are few population-level data on the changing epidemiology of perinatal HIV in South Africa (SA).
We examined data on all HIV PCR tests conducted by the SA National Health Laboratory Service in children ≤6 months of age in the Western Cape province between January 2009 and August 2015. During this period, PMTCT policies moved from zidovudine monotherapy with antiretroviral therapy (ART) for pregnant women based on CD4+ thresholds of ≤200 cells/µL before July 2010, to ≤350 cells/µL by June 2013, to ART for all HIV+ pregnant women (“Option B+”) from July 2013. Breastfeeding guidance shifted to support exclusive breastfeeding with nevirapine prophylaxis for the first 6 months of life from 2011. Analyses examined changes in HIV PCR testing (i) annually as well as (ii) by PMTCT policy period (with time lags to allow for delivery and postpartum testing), and (iii) distinguished positive tests from birth testing (conducted at ≤7 days of age) from routine early infant diagnostic (EID) testing at primary care clinics, from hospital-based testing associated with symptomatic clinical presentations.
Overall 99,684 children underwent HIV PCR testing. Among all children tested at ≤6 months of age, the HIV PCR positivity rate dropped from 5.9% in 2009 to 1.5% in 2015 (Figure); the rate of positive tests after implementation of “Option B+” (2.0%) was significantly lower than the period when ART thresholds were based on ≤350 cells/µL (2.5%; p<0.001). The mean age at first HIV PCR test decreased from 59.1 days in 2009 to 44.7 days in 2015 (p<0.001); approximately half of this change was explained by increasing numbers of HIV PCR tests conducted at birth during this period, which grew from <1% to 14% of all tests conducted (Figure). Among tests conducted beyond 7 days of age, a growing proportion took place as part of routine EID testing over time rather than hospital-based testing (p<0.001). Despite increases in birth testing, during 2014-2015 only 13% of all newly diagnosed HIV+ infants were identified through birth testing; the new infections were identified either through routine EID (56%) or hospital-based testing (31%).
There have been major reductions in perinatal HIV infections with changing PMTCT policies in this setting. Despite the rise of birth testing, the majority of HIV+ infants are still identified through routine EID programmes.